Barbara Gayle Duncan - Jun 20, 2025 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan
Stock symbol
AVIR
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/24/2025, 06:05 PM
Previous filing
May 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duncan Barbara Gayle Director 225 FRANKLIN STREET, SUITE 2100, BOSTON /s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan 2025-06-24 0001353128

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Options Exercise $0 +29.6K +89.29% $0.00 62.8K Jun 20, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Restricted Stock Units Award $0 +29.6K $0.00 29.6K Jun 20, 2025 Common Stock 29.6K Direct F1, F2
transaction AVIR Stock Option (Right to Buy) Award $0 +41.2K $0.00 41.2K Jun 20, 2025 Common Stock 41.2K $3.25 Direct F3
transaction AVIR Restricted Stock Units Options Exercise $0 -29.6K -100% $0.00 0 Jun 20, 2025 Common Stock 29.6K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
F3 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
F4 The restricted stock units vested in full on June 20, 2025.